New hope for Tough-to-Treat leukemia patients
Disease control
Not yet recruiting
This study is testing a drug called olutasidenib for adults with a specific type of acute myeloid leukemia (AML) that has returned or stopped responding to treatment. The goal is to see if the drug can help control the cancer and improve blood counts. About 25 people who have alr…
Phase: PHASE2 • Sponsor: Timothy Pardee • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC